JNSS 2015, 6(3-4):95-105 | DOI: 10.32725/jnss.2015.010

Crohn's disease and dietary recommendations

Eva Beňová1, Mária Boledovičová2,*, Kateřina Teplá3
1 Higher School of Health and Middle School of Health, Ústí nad Labem, Czech Republic
2 University of South Bohemia in České Budějovice, Faculty of Health and Social Studies, Department of Nursing and Midwifery, České Budějovice, Czech Republic
3 University of South Bohemia in České Budějovice, Faculty of Health and Social Studies, Department of Clinical and Preclinical Disciplines, České Budějovice, Czech Republic

Crohn's disease is a chronic non-specific inflammatory bowel disease of any part of the digestive tract, which has a segmental character and digestive tract affects the wall transmurally in all layers. It is a disease of multifactorial etiology. One of the presumed causes of the disease is excessive immune reactions to physiologically occurring intestinal flora in genetically predisposed individuals. Incidence in the Czech Republic is around 4-6 new cases per 100,000 inhabitants per year. Clinical manifestations of the disease are varied and are dependent on localization, extent of disease and the nature of local inflammatory changes. The most common symptoms are diarrhea, abdominal pain and weight loss. The basis for the diagnosis of disease is colonoscopic examination. Treatment of Crohn's disease is symptomatic and it is a combination of conservative and surgical treatment. Nutritional therapy is a part of the conservative treatment. Nutritional counseling is one of the basic functions of nursing in which nurse holds important educational role in cooperation with the nutritional therapist. Good nutritional status has a positive effect on the overall condition of the patient who better cope with possible acute flare. Dietary recommendations have own specifics in the period of remission and in the period of relapse. Dietary measures are designed to protect the intestinal mucosa irritation. In the remission phase of disease essential dietary measures exist. Diet is no different from a rational diet, and it is very individual. The patient must self-identify foods without the risk of pain or diarrhea. In the relapse phase should be administered diet with low residue - it is necessary to completely eliminate insoluble fiber and hard to digest foods with high fat content. In the phase of relapse may be indicated by the severity of condition parenteral or enteral nutrition.

Keywords: Crohn's disease; epidemiology; pathogenesis; dietary recommendations

Received: July 15, 2015; Accepted: October 16, 2015; Published: September 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beňová E, Boledovičová M, Teplá K. Crohn's disease and dietary recommendations. Journal of Nursing, Social Studies, Public Health and Rehabilitation. 2015;6(3-4):95-105. doi: 10.32725/jnss.2015.010.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abdulamir AS, Zaman MZ, Hafidh RR, Bakar FA (2012). The Role of Diet, Prebiotic and Probiotic in the Development and Management of Inflammatory Bowel Disease. In: Karoui, S et al. Inflammatory Bowel Disease - Advances in Pathogenesis and Management. New York: Springer, pp. 250-274. [online] [cit. 2015-01-18]. Available from: http://www.intechopen.com/books/inflammatory-bowel-disease-advances-in-pathogenesis-and-management/the-role-of-diet-and-probiotic-prebiotic-bacteria-in-the-development-protection-and-treatment-of-inf Go to original source...
    2. Baumgart DC (2012). Crohn's Disease and Ulcerative Colitis. From Epidemiology and Immunology to a Rational Diagnostic and Therapeutic Approach. New York: Springer. Go to original source...
    3. Červený P (2014). Farmaceutická péče u pacientů s idiopatickými střevními záněty [Pharmaceutical care in patients with idiopatic intestinal inflammation]. Prakt. lékáren. 10/1: 26-29 (Czech).
    4. Bernstein CN (2015). Treatment of IBD: Where We Are and Where We Are Going. Am J Gastroenterol. 110/1: 114-126. [online] [cit. 2015-01-20]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25488896 Go to original source... Go to PubMed...
    5. Dítě P. et al. (2007). Vnitřní lékařství [Internal medicine]. 2nd ed. Praha: Galén (Czech).
    6. Dítě P, Lukáš M, Lata J (2010). Idiopatické střevní záněty [Idiopatic intestinal inflammation]. In: Češka R et al. Interna [Internal medicine]. Praha: Triton, p. 400-404 (Czech).
    7. Freeman HJ (2008). Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol. 14/26: 4127-4130. [online] [cit. 2015-01-18]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725371/ Go to original source... Go to PubMed...
    8. Hindryckx P, Laukens D (2012). Intestinal Barrier Dysfunction: The Primary Driver of IBD? In: Karoui, S et al. Inflammatory Bowel Disease - Advances in Pathogenesis and Management. New York: Springer, pp. 24-40. [online] [cit. 2015-01-18]. Available from: http://www.intechopen.com/books/inflammatory-bowel-disease-advances-in-pathogenesis-and-management/intestinal-barrier-dysfunction-the-primary-driver-of-ibd Go to original source...
    9. Hybenová E, Štofirová J, Mikulajová A (2013). Celiac disease and gluten-free diet. Potravinárstvo. 7/1: 95-100. [online] [cit. 2015-02-17]. Available from: http://dx.doi.org/10.5219/276 Go to original source...
    10. Jirásek V (2002). Crohnova nemoc [Crohn's disease]. In: Jirásek V, Brodanová M, Mareček Z. Gastroenterologie a hepatologie [Gastroenterology and hepathology]. Praha: Galén, pp. 92-99 (Czech).
    11. Kala Z, Marek F, Válek V, Bartušek D (2014). Chirurgická léčba Crohnovy choroby [Surgical treatment of Crohn's disease]. Vnitř Lék. 60/7-8: 617-623 (Czech).
    12. Kohout P (2004). Výživa u pacientů s idiopatickými střevními záněty [Nutrition in patients with idiopatic intestinal inflammation]. Praha: Maxdorf (Czech).
    13. Kohout P (2011). Výživa u pacientů s idiopatickými střevními záněty [Nutrition in patients with idiopatic intestinal inflammation]. Postgraduální med. 13/2: 122-127 (Czech).
    14. Konečný M, Ehrmann J (2014). Pokroky v diagnostice a léčbě nespecifických střevních zánětů [Progress in diagnosis and treatment of non-specific intestinal inflammation]. Vnitř Lék. 60/7-8: 625-629 (Czech).
    15. Kužela L, Zakuciová M (2012). Racionálna liečba chronických nešpecifických zápalov čreva. Štandardný diagnostický a terapeutický postup. Metodický list racionálnej farmakoterapie a liekovej politiky MZ SR [Rational treatment of chronic non-specific intestinal inflammation. Standard, diagnosis and therapeutic process. Methodological list of rational pharmacotherapy and drug policy of the Ministry of Health of the Slovak Republic.]. 15/5-7: 2-8. [online] [cit. 2015-02-13]. Available from: http://www.sgssls.sk/files/publikacie/metodicke-listy/ml-zapaly-creva-2012-final.pdf (Slovak).
    16. Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schütz T et al. (2006). ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clinical Nutrition. 25/2: 275-284. [online] [cit. 2015-03-14]. Available from: http://espen.info/documents/ENGastro.pdf Go to original source... Go to PubMed...
    17. Lukáš M (2009). Farmakoterapie idiopatických střevních zánětů [Pharmacotherapy of idiopatic intestinal inflammation]. Prakt. lékáren. 5/4: 164-167 (Czech).
    18. Lukáš M (2011). Možnosti medikamentózní léčby u Crohnovy nemoci a ulcerózní kolitidy [Possibilities of medicamentous treatment of Crohn's disease and ulcerous colitis]. Interní med. 13/11: 422-426 (Czech).
    19. Lukáš M (2012). Idiopatické střevní záněty [Idiopatic intestinal inflammation]. In: Klener P et al. Vnitřní lékařství [Internal medicine]. Praha: Galén, pp. 611-619 (Czech).
    20. Lukáš M (2013). Současnost a budoucnost v léčbě Crohnovy nemoci [Present and future in treatment of Crohn's disease]. Gastroent Hepatol. 77/4: 306-312 (Czech).
    21. Lukáš M (2014a). Etiologie a patogeneze idiopatických střevních zánětů [Ethyology and pathogenesis of idiopatic intestinal inflammation]. Vnitř. Lék. 60/7-8: 640-644 (Czech).
    22. Lukáš M (2014b). Perspektivy biologické léčby u idiopatických střevních zánětů [Perspectives of biological treatment of idiopatic intestinal inflammation]. Gastroenterol Hepatol. 68/3: 225-229 (Czech).
    23. Lyra A, Lahtinen S (2012). Dysbiosis of the Intestinal Microbiota in IBS. In: Lule G. Current Concepts in Colonic Disorders. New York: Springer, p. 262-276. [online] [cit. 2015-04-11]. Available from: http://www.intechopen.com/books/current-concepts-in-colonic-disorders/dysbiosis-of-the-intestinal-microbiota-in-ibs Go to original source...
    24. Novotná H (2013a). Dieta při zánětlivých chorobách střevních [Diet in inflammatory intestinal diseases]. In: Holubová A, Novotná H, Marečková J. Ošetřovatelská péče v gastroenterologii a hepatologii [Nursing care in gastroenterology and hepatology]. Praha: Mladá fronta, pp. 215-216 (Czech).
    25. Novotná H (2013b). Podávání enterální výživy - péče o pacienta [Providing enternal nutrition - patient care]. In: Holubová, A, Novotná H, Marečková J. Ošetřovatelská péče v gastroenterologii a hepatologii [Nursing care in gastroenterology and hepatology]. Praha: Mladá fronta, pp. 193-201 (Czech).
    26. Novotná H. (2013c). Podávání parenterální výživy - péče o pacienta [Providing parenteral nutrition - patient care]. In: Holubová A, Novotná H, Marečková J. Ošetřovatelská péče v gastroenterologii a hepatologii [Nursing care in gastroenterology and hepatology]. Praha: Mladá fronta, pp. 203-208 (Czech).
    27. Šachlová M (2011). Jakou volit stravu u pacientů s Crohnovou chorobou? [Which diet in patients with Crohn's disease] Interní Med. 13/10: 403-405 (Czech).
    28. Van Gossum A, Cabre E, Hébuterne X, Jappesen P, Krznaric Z, Messing B et al. (2009). ESPEN Guidelines on Parenteral Nutrition: Gastroenterology. Clinical Nutrition. 28/4: 415-427. [online] [cit. 2015-04-21]. Available from: http://espen.info/documents/0909/Gastroenterology.pdf Go to original source... Go to PubMed...
    29. Vrzalová D, Konečný M, Ehrmann J (2011). Enterální a parenterální výživa u pacientů s nespecifickými střevními záněty [Enteral and parenteral nutrition in patients with non-specific intestinal inflammation]. Med. Praxi. 8/7-8: 337-338 (Czech).
    30. Yutao Y (2012). Pathogenesis of Inflammatory Bowel Disease. In: Karoui S et al. Inflammatory Bowel Disease - Advances in Pathogenesis and Management. New York: Springer, pp. 111-134. [online] [cit. 2015-01-30]. Available from: http://www.intechopen.com/books/inflammatory-bowel-disease-advances-in-pathogenesis-and-management/advance-in-the-pathogenesis-of-inflammatory-bowel-diseases
    31. Zbořil V (2013). Endoskopické metody v racionální diagnostice a terapii idiopatických střevních zánětů [Endoscopic methods in rational diagnosis and therapy of idiopatic intestinal inflammation]. Čas. lék. čes. 152/6: 280-283 (Czech).
    32. Zbořil V (2015). Nutriční postupy [Nutrition procedures]. [online] [cit. 2015-02-01] Available from: http://www.crohnovanemoc.cz/zakladni-lecebne-metody/nutricni-postupy/dieta.html (Czech).
    33. Zbořil V, Prokopová L (2010). Idiopatické střevní záněty - Crohnova nemoc [Idiopatic intestinal inflammation - Crohn's disease]. In: Bureš J, Vaňásek T et al. Gastroenterologie [Gastroenterology]. Praha: Galén, pp. 99-102 (Czech).

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content